Pembrolizumab lowered risk of stage IIb/c melanoma recurrence
The immunotherapy medication pembrolizumab, approved for the treatment of stage III and IV melanoma, has been shown to reduce...
Pembrolizumab lowered risk of stage IIb/c melanoma recurrence
Accuracy of dermoscopy structures and patterns clarified in melanoma detection
VIDEO: Majority of fluorinated compounds in cosmetics are unlabeled, new research suggests
VIDEO: High testosterone levels in men may be linked to increased risk of melanoma
VIDEO: Covid 19 caused delay in skin cancer diagnoses
Role of IL-33 in skin cancer clarified
Software spots 'ugly duckling' lesions in wide-field photos
VIDEO: Non-surgical injection developed for skin cancer